Connect with us

Business

Viscount Systems, Inc. (VSYS) Appoints Security and Access Control Industry Veteran Dennis Raefield COO Ahead of Freedom Platform Growth

Published

on

Viscount Systems (OTCQB: VSYS), the developers of cutting-edge security/entry control systems and emergency planning software platforms, reported recently that industry veteran and former president of $100M-plus Honeywell International division, Honeywell Access Systems, Mr. Dennis Raefield, has been appointed Chief Operating Officer.

This is a clear move by management to bump up from the company’s Board, adding a man who has one of the most impressive track records out there for handling some of the industry’s biggest access control companies. Shrewd move by VSYS as its paradigm-shattering Freedom platform gains dominance. The company is going to need a guy like Raefield, with all of his nuanced insights into the minutiae of the game, in order to handle the kind of growth potentially headed the company’s way as a result of Freedom.

Freedom is a first-of-its-kind solution, bringing native U.S. Government FIPS 201-2 initiative support and solid interaction with Microsoft’s Active Directory together to deliver an unprecedented combination of robust security and ease of use/overall functionality. Freedom is the first and only solution to hit the market that allows standard, already in-place IT networks to support entry devices and building automation systems without any kind of costly PC-programmed control panels.

This simple, elegant workaround changes everything, slashing as much as 80% off the investment required to execute on a traditional system and even after you’ve got those traditional systems installed you are still dealing with a bunch of hassle configuring, monitoring, and interacting with a bunch of cumbersome control panels. Moreover, Freedom is designed to easily integrate with extant LDAP (logical IT security software) components of the given solution, completely replacing the control panel and clunky software of the traditional system in one fell swoop.

Freedom levels the playing field for building operators, dramatically reducing the cost, complexity, and time required to get the access/security job done. This software silver bullet also shunts the threat from cyber security breaches typically associated with those atavistic control panels, delivering ingress/egress commands via a tiny IP-enabled device (appearing within the network as another mac-addressable device). This is a one-stop-shop solution for intuitive control of the entire facility, meaning you can implement an enterprise-wide solution cheaply and get superior results at the same time.

Raefield has his work cut out for him, but he is also the perfect person for the job and will be working closely with the CEO of VSYS, Stephen Pineau, as they hammer out the roadmap for what will no doubt be a major growth spurt for the company. Taking things to the next level with the Raefield appointment was a popular decision and even a cursory look at his distinguished career banishes all notions to the contrary. In addition to his leadership at Honeywell’s enterprise-level access control system manufacturing division that serves Fortune 100 clients, Raefield also used to run security systems integration shop, Pinkerton Systems Integration (Securitas), as President of the $70M-plus company with numerous Fortune 500 clients. Raefield got his BS in Mechanical Engineering at Santa Clara University and went on to be Owner and CEO at premier San Francisco area systems integrator, Omega Corporate Security. Raefield is also a member of several key security and systems organizations like ASIS, CAA, CSAA, ESA, ISIO, and SIA.

Pineau hailed the Raefield appointment as an essential addition to the management team at a key phase in the company’s evolution and assured investors that the vast experience he brings to the table will translate directly into shareholder growth.

Raefield was keen to remark that the infrastructure required to compensate for the coming meteoric rise of the Freedom platform would indeed require a lot of direct work with Pineau as the COO. Work which should result in the kind of visionary direction needed for the VSYS team to cope with the inevitable growing pains, as the Freedom access control platform gobbles up market share.

To obtain more information on Viscount Systems, visit www.Viscount.com

Continue Reading

Business

Top 3 Gainers: Zynga (NASDAQ:ZNGA), Eros International (NYSE:EROS), Borqs Technologies’ (BRQS)

Published

on

By

Zynga (NASDAQ:ZNGA) is up 2.5% after Benchmark reiterated its Buy rating in a look-ahead at Q2 earnings. The firm’s expecting a beat and solid guidance for Q3, and it’s raising its guidance for the fiscal year.

Tailwinds from the pandemic won’t dissipate easily, Benchmark suggests, and the videogame maker’s acquisition of Peak (and with it new “forever franchises” in Toon Blast and Toy Blast) will drive audience, bookings, margins and free cash flow, it says. The firm has an $11 price target, now implying 14% upside.

Eros International (NYSE:EROS) is up 5.8% today, making up the last week’s lost ground, after news that its streaming service Eros Now is partnering with Sony India (SNE +2.3%).

That will mean Eros Now’s app is pre-installed on selected Sony smart televisions in India, along with availability on a large base of existing models (Bravia E series and newer).

The country over the past year has seen a 25% growth in demand for smart TVs, fueled by overall industry growth of 15%, to a record 15M units/year.

Borqs Technologies’ (BRQS) personal safety tracker sees strong market with increased orders from the electronics retail chain in the US.

The boost in product demand comes ahead coronavirus pandemic that provides company to expect delivery of 250K units this year. It reflects over 3x the volume delivered in 2019, the year of its launch.

Borqs’ mobile personal safety devices designed particularly for senior citizens come with panic button, location tracking, and fall detection.

Continue Reading

Biotech

Biotech movers: Pfizer Inc. (PFE), Celgene Corporation (CELG)

Published

on

Pfizer Inc. (PFE) said on Thursday it received a request for documents as part of a U.S. investigation related to quality issues involving the manufacture of auto-injectors at its Meridian Medical Technologies site.

Pfizer, in a regulatory filing, said it would be producing records in response to the civil investigative demand from the U.S. Attorney’s office for the Southern District of New York.

Why ASDN Could Massively Outperform PFE in 2019

Meridian, a unit of Pfizer that manufactures EpiPen injectors used to deliver an emergency allergy antidote, has been hit by a series of manufacturing problems in recent years. Mylan NV, which markets EpiPens, has recalled tens of thousands of the devices after complaints that some had failed to activate.

Bristol-Myers Squibb has been meeting with shareholders in Boston and New York over the last two weeks to try to salvage its $74 billion purchase of cancer drugmaker Celgene Corporation (CELG), the biggest acquisition announced so far this year.

Why Investors Are Calling ASDN the CELG of the Sky!

The deal, announced in January, was hard sell to Bristol shareholders from the start. The acquisition adds about $32 billion in fresh debt to Bristol’s balance sheet while assuming $20 billion in Celgene’s debt, the companies said at the time. After factoring in debt, the acquisition was the largest health-care deal on record, according to data compiled by Refinitiv.

Now, hedge funds Wellington Management and Starboard Value say the deal doesn’t sit well with them. Bristol has sent executives to New York to meet with institutional investors several times over the last two weeks and met with investors in Boston on Wednesday and Thursday, according to a person who briefed on the meetings.

Bristol-Myers declined to comment.

Continue Reading

Biotech

Big Losers: Corbus Pharmaceuticals Holdings, Inc. (CRBP), Petróleo Brasileiro S.A. – Petrobras (PBR)

Published

on

Corbus Pharmaceuticals Holdings, Inc. (CRBP)’s shares slumped as much as 16% to $6.94 on huge volume. The stock has been showing intense sell off suddenly after a bearish article on seekingalph.com by Alpha Exposure.

The article stated that Corbus has ties to investors convicted of or alleged to have committed securities fraud. We believe lenabasum has failed its major trials in SSc and CF. Lenabasum was also denied Breakthrough Therapy Designation in SSc. We believe lenabasum will fail in its pivotal SSc and Phase 2b CF trials. We are short Corbus with a price target of $0.50.

Wow the future of Autonomous flight is finally here with the launch of ASDN passenger drone Elroy

Petróleo Brasileiro S.A. – Petrobras (PBR) is expanding its ambitious divestment program and has “bold” plans for sales, the Brazilian state-run oil company’s chief executive said after the firm posted its first annual profit in five years.

On a conference call with analysts to discuss fourth-quarter results, CEO Roberto Castello Branco said selling non-core assets will be key to deleveraging.

Petrobras, as the company is known, can reduce its ratio of net debt to earnings before interest, taxes, depreciation and amortization, or EBITDA, to 1.5 or even to 1, he added.

The University of Chicago-educated CEO, who took the reins in early January, has long been vocal about the need to slim down the sprawling firm and focus on core activities such as exploration and production. Thursday’s comments were some of his most assertive on the matter.

Why Investors Are Calling ASDN the TPC of the Sky!

Continue Reading
Advertisement

Trending